Christine K. Lane
Areas of Focus
Overview
Clients turn to Christine Lane for her strategic, practical, and straightforward business approach to navigating complex transactional tax matters, including domestic and cross-border mergers, acquisitions, joint ventures, restructurings, and reorganizations. As partner and chair of Crowell's Tax Group, Christine represents clients across a wide range of industry sectors, including health care and life sciences, insurance, technology, and manufacturing. Christine routinely represents Fortune 50 and 100 clients in their tax planning and M&A transactions. She also represents emerging companies, private equity funds, and family offices with their tax planning and transactional needs.
Career & Education
- Department of the Treasury
Attorney, IRS, Office of Chief Counsel, 2006–2011
- Department of the Treasury
- Georgetown University Law Center, LL.M., with distinction, 2013
- Florida State University College of Law, J.D., cum laude, Order of the Coif, 2006
- University of Miami, B.B.A., summa cum laude, 2002
- District of Columbia
- U.S. Tax Court
Christine's Insights
Client Alert | 6 min read | 07.22.25
The One Big Beautiful Bill Act Expands Favorable QSBS Treatment
On July 4, 2025, President Trump signed into law the One Big Beautiful Bill Act (the “Act”), after it was passed by Congress on July 3, 2025. Notably, the Act made significant and welcome changes from the perspective of startup company stockholders and venture capital investors to the qualified small business stock (“QSBS”) rules set forth in Internal Revenue Code (“Code”) Section 1202. In a nutshell, the changes modernize (by adjusting for inflation) and expand the already favorable tax treatment for QSBS under Code Section 1202. The Act also permanently reinstates elective expensing for qualifying domestic research and experimental expenditures that will likely help more startups in research and capital intensive sectors qualify for favorable QSBS treatment.
Client Alert | 3 min read | 07.08.25
Trump Administration Announces Clean Energy Tax Credit Enforcement Ramp Up
Firm News | 1 min read | 07.01.25
Crowell Represents Parsons Corporation in Strategic $89M Acquisition
Client Alert | 5 min read | 05.05.25
Recognition
- Legal 500 US: Tax, 2017–2020
Christine's Insights
Client Alert | 6 min read | 07.22.25
The One Big Beautiful Bill Act Expands Favorable QSBS Treatment
On July 4, 2025, President Trump signed into law the One Big Beautiful Bill Act (the “Act”), after it was passed by Congress on July 3, 2025. Notably, the Act made significant and welcome changes from the perspective of startup company stockholders and venture capital investors to the qualified small business stock (“QSBS”) rules set forth in Internal Revenue Code (“Code”) Section 1202. In a nutshell, the changes modernize (by adjusting for inflation) and expand the already favorable tax treatment for QSBS under Code Section 1202. The Act also permanently reinstates elective expensing for qualifying domestic research and experimental expenditures that will likely help more startups in research and capital intensive sectors qualify for favorable QSBS treatment.
Client Alert | 3 min read | 07.08.25
Trump Administration Announces Clean Energy Tax Credit Enforcement Ramp Up
Firm News | 1 min read | 07.01.25
Crowell Represents Parsons Corporation in Strategic $89M Acquisition
Client Alert | 5 min read | 05.05.25
Insights
- |
09.26.23
The Journal of Federal Agency Action
TEI's 2024 Credits and Incentives Seminar
|06.19.24
Christine's Insights
Client Alert | 6 min read | 07.22.25
The One Big Beautiful Bill Act Expands Favorable QSBS Treatment
On July 4, 2025, President Trump signed into law the One Big Beautiful Bill Act (the “Act”), after it was passed by Congress on July 3, 2025. Notably, the Act made significant and welcome changes from the perspective of startup company stockholders and venture capital investors to the qualified small business stock (“QSBS”) rules set forth in Internal Revenue Code (“Code”) Section 1202. In a nutshell, the changes modernize (by adjusting for inflation) and expand the already favorable tax treatment for QSBS under Code Section 1202. The Act also permanently reinstates elective expensing for qualifying domestic research and experimental expenditures that will likely help more startups in research and capital intensive sectors qualify for favorable QSBS treatment.
Client Alert | 3 min read | 07.08.25
Trump Administration Announces Clean Energy Tax Credit Enforcement Ramp Up
Firm News | 1 min read | 07.01.25
Crowell Represents Parsons Corporation in Strategic $89M Acquisition
Client Alert | 5 min read | 05.05.25
